Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
11.43
+0.16 (1.42%)
Nov 22, 2024, 4:00 PM EST - Market closed
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $605.41 million as of November 22, 2024. Its market cap has increased by 217.13% in one year.
Market Cap
605.41M
Enterprise Value
341.57M
1-Year Change
217.13%
Ranking
Category
Stock Price
$11.43
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has decreased from $804.46M to $605.41M, a decrease of -24.74%. That is a compound annual growth rate of -5.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 614.95M | 161.81% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | 2.24B | 142.11% |
| Dec 31, 2019 | 926.91M | 15.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 618.69M |
| Standard BioTools | 603.06M |
| Simulations Plus | 602.82M |
| Dianthus Therapeutics | 599.93M |
| Altimmune | 597.80M |
| Mineralys Therapeutics | 590.75M |
| Immunome | 587.97M |
| EyePoint Pharmaceuticals | 585.84M |